Detalhe da pesquisa
1.
Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue.
J Mol Cell Cardiol
; 97: 82-92, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27108529
2.
The E3 ubiquitin ligase Asb2ß is downregulated in a mouse model of hypertrophic cardiomyopathy and targets desmin for proteasomal degradation.
J Mol Cell Cardiol
; 87: 214-24, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26343497
3.
Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy.
Hum Mol Genet
; 21(14): 3237-54, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22523091
4.
FHL2 expression and variants in hypertrophic cardiomyopathy.
Basic Res Cardiol
; 109(6): 451, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25358972
5.
Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.
Basic Res Cardiol
; 108(3): 349, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23572067
6.
Ranolazine antagonizes catecholamine-induced dysfunction in isolated cardiomyocytes, but lacks long-term therapeutic effects in vivo in a mouse model of hypertrophic cardiomyopathy.
Cardiovasc Res
; 109(1): 90-102, 2016 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26531128
7.
I-1-deficiency negatively impacts survival in a cardiomyopathy mouse model.
Int J Cardiol Heart Vasc
; 8: 87-94, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28785686
8.
Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy.
Front Physiol
; 5: 484, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25566086
9.
Rescue of cardiomyopathy through U7snRNA-mediated exon skipping in Mybpc3-targeted knock-in mice.
EMBO Mol Med
; 5(7): 1128-45, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23716398